- Confirmed objective response rate of 40% in PD-L1 positive patients with no prior checkpoint inhibitor therapy - Median progression-free survival of 6.3 months in PD-L1 positive patients at.
Capturing immunotherapy response in a blood drop sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.
Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).